[go: up one dir, main page]

GB201900361D0 - Polypeptide and vaccine - Google Patents

Polypeptide and vaccine

Info

Publication number
GB201900361D0
GB201900361D0 GBGB1900361.5A GB201900361A GB201900361D0 GB 201900361 D0 GB201900361 D0 GB 201900361D0 GB 201900361 A GB201900361 A GB 201900361A GB 201900361 D0 GB201900361 D0 GB 201900361D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1900361.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
One Health Ventures Ltd
Original Assignee
One Health Ventures Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by One Health Ventures Ltd filed Critical One Health Ventures Ltd
Priority to GBGB1900361.5A priority Critical patent/GB201900361D0/en
Publication of GB201900361D0 publication Critical patent/GB201900361D0/en
Priority to CN202510538987.0A priority patent/CN120392991A/en
Priority to CA3092804A priority patent/CA3092804A1/en
Priority to PCT/GB2019/050588 priority patent/WO2019166830A1/en
Priority to US16/976,869 priority patent/US12144854B2/en
Priority to CN201980016070.7A priority patent/CN111787943B/en
Priority to AU2019227860A priority patent/AU2019227860B2/en
Priority to EP19716474.2A priority patent/EP3758744B1/en
Priority to ES19716474T priority patent/ES2985984T3/en
Priority to ZA2020/05261A priority patent/ZA202005261B/en
Priority to US18/915,091 priority patent/US20250381258A1/en
Ceased legal-status Critical Current

Links

GBGB1900361.5A 2018-03-02 2019-01-10 Polypeptide and vaccine Ceased GB201900361D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1900361.5A GB201900361D0 (en) 2019-01-10 2019-01-10 Polypeptide and vaccine
ES19716474T ES2985984T3 (en) 2018-03-02 2019-03-01 Clostridium perfringens epsilon toxin as a vaccine
US16/976,869 US12144854B2 (en) 2018-03-02 2019-03-01 Epsilon toxin from clostridium perfringens as a vaccine
CA3092804A CA3092804A1 (en) 2018-03-02 2019-03-01 Epsilon toxin from clostridium perfringens as a vaccine
PCT/GB2019/050588 WO2019166830A1 (en) 2018-03-02 2019-03-01 Epsilon toxin from clostridium perfringens as a vaccine
CN202510538987.0A CN120392991A (en) 2018-03-02 2019-03-01 Epsilon toxin from Clostridium perfringens as a vaccine
CN201980016070.7A CN111787943B (en) 2018-03-02 2019-03-01 Epsilon toxin from Clostridium perfringens as a vaccine
AU2019227860A AU2019227860B2 (en) 2018-03-02 2019-03-01 Epsilon toxin from clostridium perfringens as a vaccine
EP19716474.2A EP3758744B1 (en) 2018-03-02 2019-03-01 Epsilon toxin from clostridium perfringens as a vaccine
ZA2020/05261A ZA202005261B (en) 2018-03-02 2020-08-24 Epsilon toxin from clostridium perfringens as a vaccine
US18/915,091 US20250381258A1 (en) 2018-03-02 2024-10-14 Epsilon toxin from clostridium perfringens as a vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1900361.5A GB201900361D0 (en) 2019-01-10 2019-01-10 Polypeptide and vaccine

Publications (1)

Publication Number Publication Date
GB201900361D0 true GB201900361D0 (en) 2019-02-27

Family

ID=65528111

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1900361.5A Ceased GB201900361D0 (en) 2018-03-02 2019-01-10 Polypeptide and vaccine

Country Status (1)

Country Link
GB (1) GB201900361D0 (en)

Similar Documents

Publication Publication Date Title
IL287781A (en) Clec12a-binding polypeptides and uses thereof
ZA201708218B (en) Recombinant yeast and use thereof
IL281224A (en) Peptide vaccines
GB2600592B (en) Polypeptide and use thereof
IL290414A (en) Atf5 peptide variants and uses thereof
IL287782A (en) Cd33-binding polypeptides and uses thereof
SG11202006669RA (en) Peptides and uses thereof
SG11202111462VA (en) Asx-specific protein ligases and uses thereof
GB201819200D0 (en) Polypeptide and uses thereof
IL290643A (en) Delivery peptides and methods of using the same
GB202201003D0 (en) Fusion polypeptide and use thereof
EP3947418C0 (en) Peptides and use thereof
IL278830A (en) Reverse peptide vaccine
SG11202101090RA (en) Cdca1-derived peptide and vaccine containing same
GB202201004D0 (en) Reconbinant fusion polypeptide and use thereof
EP3897691A4 (en) Il-10-containing vaccines and uses thereof
SG11202007887VA (en) Cyclic peptides and uses thereof
IL282245A (en) Vaccine polypeptide compositions and methods
HUP1700012A2 (en) Novel proteins and use thereof
GB201902902D0 (en) Polypeptide and vaccine
GB201900361D0 (en) Polypeptide and vaccine
GB201803401D0 (en) Polypeptide and vaccine
GB201803388D0 (en) Polypeptide and vaccine
GB202003926D0 (en) Polypeptide and vaccine
IL290401A (en) Peptide antigens and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)